Sabra Healthcare Reit Stock News

Sabra (SBRA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear

Sabra (SBRA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ear

These REITs offer higher yields but have higher risk profiles.

Sabra Healthcare REIT Inc (SBRA) shares closed today at 1.5% above its 52 week low of $13.01, giving the company a market cap of $3B. The stock is currently down 18.2% year-to-date, down 18.3% over the past 12 months, and down 8.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 19.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -160.8% The company's stock price performance over the past 12 months lags the peer average by -184.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Wall Street brokerages expect that Sabra Health Care REIT, Inc. (NASDAQ:SBRA) will post $153.35 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Sabra Health Care REITs earnings. The highest sales estimate is $155.30 million and the lowest is $150.30 million. Sabra Health Care REIT posted []

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) shares reached a new 52-week low on Friday . The stock traded as low as $14.06 and last traded at $14.10, with a volume of 37074 shares changing hands. The stock had previously closed at $14.31. SBRA has been the subject of several research analyst reports. Zacks Investment Research []

Looking at government assistance with a broad lens, this pair of REITs would see huge benefits from more federal cash.

Looking at government assistance with a broad lens, this pair of REITs would see huge benefits from more federal cash.

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been assigned a consensus recommendation of Buy from the thirteen ratings firms that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year target price among []

Sabra Health Care REIT (NASDAQ:SBRA) issued an update on its FY 2021 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.510-$1.530 for the period. The company issued revenue guidance of -. SBRA stock traded up $0.05 during midday trading on Friday, reaching $14.75. 2,787,855 shares of the companys stock []

Sabra Health Care REIT reported weak Q3-2021 results.

Sabra Health Care REIT, Inc. (SBRA) CEO Rick Matros on Q3 2021 Results - Earnings Call Transcript

Sabra (SBRA) delivered FFO and revenue surprises of 0.00% and -9.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

October portfolio value is up 3.27% from September and 16.3% year to date including dividends.

IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced the closing of two investments and the transition of three fac